Document is current
Any future updates will be listed below
-
Authors
Körver, Simon https://orcid.org/0000-0003-1432-7760
Geurtsen, Gert J.
Hollak, Carla E. M.
van Schaik, Ivo N.
Longo, Maria G. F. https://orcid.org/0000-0001-6819-4890
Lima, Marjana R.
Vedolin, Leonardo
Dijkgraaf, Marcel G. W.
Langeveld, Mirjam
-
Funding
Funding for this research was provided by:
Academisch Medisch Centrum (Innovation grant 2014)
- License Information
-
More Information
Article History
Received: 9 July 2018
Accepted: 4 December 2018
First Online: 17 January 2019
Competing Interests
: Simon Körver, Gert J. Geurtsen, Maria G.F. Longo, Marjana R. Lima, Leonardo Vedolin and Marcel G.W. Dijkgraaf declare no competing interests. Carla E.M. Hollak declares that Sphinx (through AMC-research BV) is involved in pre-marketing studies with Sanofi-Genzyme, Protalix and Idorsia; she does not have any other financial relationship with pharmaceutical companies and reports no nonfinancial competing interests. Ivo N. van Schaik chairs a steering committee for CSL Behring and received departmental honoraria for serving on scientific advisory boards for CSL Behring and Baxter. All lecturing and consulting fees for INS were donated to the Stichting Klinische Neurologie, a local foundation that supports research in the field of neurological disorders. He reports no non-financial competing interests. Mirjam Langeveld declares that Sphinx (through AMC-research BV) is involved in pre-marketing studies with Sanofi- Genzyme, Protalix and Idorsia; she does not have any other financial relationship with pharmaceutical companies and reports no nonfinancial competing interests.
